Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Tager

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
American Journal of Respiratory Cell and Molecular Biology|November 6, 2012
Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesisAndrew M Tager
Biochimica Et Biophysica Acta|March 19, 2013
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisNorihiko Sakai, Andrew M Tager
The Journal of Infectious Diseases|October 24, 2013
Humoral immunity in humanized mice: a work in progressEdward Seung, Andrew M Tager
Current Opinion in Virology|August 16, 2017
Humanized mouse models of latent HIV infectionMaud Deruaz, Andrew M Tager
Proceedings of the American Thoracic Society|July 18, 2012
Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosisBarry S Shea, Andrew M Tager
Nature Reviews. Immunology|September 3, 2004
T-cell trafficking in asthma: lipid mediators grease the wayAndrew D Luster, Andrew M Tager
The Open Rheumatology Journal|July 18, 2012
Sphingolipid regulation of tissue fibrosisBarry S Shea, Andrew M Tager
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 5, 2003
BLT1 and BLT2: the leukotriene B(4) receptorsAndrew M Tager, Andrew D Luster
The New England Journal of Medicine|May 4, 2012
The monocyte in atherosclerosis--should I stay or should I go now?Robert E Gerszten, Andrew M Tager
The New England Journal of Medicine|October 16, 2009
Case records of the Massachusetts General Hospital. Case 32-2009. A 27-year-old man with progressive dyspneaAndrew M Tager, Amita Sharma, Eugene J Mark
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
American Journal of Respiratory Cell and Molecular Biology|November 6, 2012
Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesisAndrew M Tager
Biochimica Et Biophysica Acta|March 19, 2013
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisNorihiko Sakai, Andrew M Tager
The Journal of Infectious Diseases|October 24, 2013
Humoral immunity in humanized mice: a work in progressEdward Seung, Andrew M Tager
Current Opinion in Virology|August 16, 2017
Humanized mouse models of latent HIV infectionMaud Deruaz, Andrew M Tager
Proceedings of the American Thoracic Society|July 18, 2012
Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosisBarry S Shea, Andrew M Tager
Nature Reviews. Immunology|September 3, 2004
T-cell trafficking in asthma: lipid mediators grease the wayAndrew D Luster, Andrew M Tager
The Open Rheumatology Journal|July 18, 2012
Sphingolipid regulation of tissue fibrosisBarry S Shea, Andrew M Tager
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 5, 2003
BLT1 and BLT2: the leukotriene B(4) receptorsAndrew M Tager, Andrew D Luster
The New England Journal of Medicine|May 4, 2012
The monocyte in atherosclerosis--should I stay or should I go now?Robert E Gerszten, Andrew M Tager
The New England Journal of Medicine|October 16, 2009
Case records of the Massachusetts General Hospital. Case 32-2009. A 27-year-old man with progressive dyspneaAndrew M Tager, Amita Sharma, Eugene J Mark
Pageof 12